|801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.Chinafirstname.lastname@example.org|
|Place of Origin:||China|
|Model Number:||Tablets, 0.125g/0.25g|
|Minimum Order Quantity:||one million pills|
|Packaging Details:||Packing 10 x 10/box|
|Delivery Time:||45 days|
|Supply Ability:||One million pills per day|
|Product:||Cephalexin Tablets, Cefalexin Tablets||Specification:||Tablets, 0.125g/0.25g|
|Standard:||BP, EP||Packing:||10 X 10/box|
Cephalexin Tablets, Cefalexin Tablets, 0.125g/0.25g , Oral Medications
Product : Cephalexin Tablets, Cefalexin Tablets, Ampicillin Tablets
Strength : 0.125g/0.25g
Packing : 10 x 10/box
Standard : BP, EP
These Cefalexin Tablets is indicated in the treatment of the following infections: Respiratory tract infections; bone and joint infections; genito urinary infections, including acute prostatitis and dental infections.
Cefalexin Tablets is active against the following organisms: Beta-haemolytic streptococci; staphylococci, including coagulase-positive, coagulase-negative and penicillinase-producing strains; streptococcus pneumoniae; escherichia coli; proteus mirabilis; klebsiella species, haemophilus influenzae; branhamella catarrhalis.
Most strains of enterococci (streptococcus faecalis) and a few strains of staphylococci are resistant to cefalexin.
Cefalexin Tablets is not active against most strains of enterobacter species, morganella morganii, pseudomonas or herellea species.
For the treatment of respiratory tract infections caused by Streptococcus pneumoniae and Streptococcus pyogenes; otitis media due to Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Moraxella catarrhalis; skin and skin structure infections caused by Staphylococcus aureus and/or Streptococcus pyogenes; bone infections caused by Staphylococcus aureus and/or Proteus mirabilis; genitourinary tract infections, including acute prostatitis, caused by Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.
Cephalexin (also called Cefalexin) is a first generation cephalosporin antibiotic. It is one of the most widely prescribed antibiotics, often used for the treatment of superficial infections that result as complications of minor wounds or lacerations. It is effective against most gram-positive bacteria.
Mechanism of action
Cephalexin, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cephalexin interferes with an autolysin inhibitor.
Contact Person: Luke Liu